Browsing Tag
GSDIa
1 post
Ultragenyx (Nasdaq: RARE) wins FDA approval for $2.7m Genglycos gene therapy
Genglycos becomes the first approved treatment for glycogen storage disease type Ia, but accelerated approval rests on reduced cornstarch use as a surrogate endpoint and requires confirmatory evidence.